We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.21%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.44B
AUM Growth
+$25.6M
(+0.47%)
Cap. Flow
+$82.4M
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
760
New
155
Increased
313
Reduced
140
Closed
45
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$51.9M |
| 2 |
Meta Platforms (Facebook)
META
|
+$42.1M |
| 3 |
TripAdvisor
TRIP
|
+$33.4M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$31.2M |
| 5 |
Methanex
MEOH
|
+$26.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKQ Corp
LKQ
|
+$54.6M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$51.3M |
| 3 |
Amazon
AMZN
|
+$40.3M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$39.9M |
| 5 |
Copa Holdings
CPA
|
+$38.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.2% |
| 2 | Consumer Discretionary | 15.8% |
| 3 | Industrials | 13.42% |
| 4 | Technology | 13.22% |
| 5 | Healthcare | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
DELISTED
Annaly Capital Management, Inc. 7.50% Series D Cumulative Redeemable Preferred Stock
NLY.PRD
| $1.93M | 0.04% |
81,595
+9,295
| +13% | +$215K |
2013 Q2
3 quarters
|
|
202
Alkermes
ALKS
$6.73B
| $1.9M | 0.03% |
+43,126
| New | +$2.05M |
2014 Q1
0 quarters
|
|
|
KFN.PR.CL
203
DELISTED
KKR Financial Holdings LLC
KFN.PR.CL
| $1.89M | 0.03% |
73,520
+4,000
| +6% | +$99.7K |
2013 Q2
3 quarters
|
|
204
MPLX
MPLX
$57.9B
| $1.85M | 0.03% |
+37,700
| New | +$1.75M |
2014 Q1
0 quarters
|
|
|
SSW.PRD
205
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
| $1.8M | 0.03% |
71,365
+1,565
| +2% | +$39.4K |
2013 Q4
1 quarter
|
|
|
SAQ.CL
206
DELISTED
Saratoga Investment Corp.
SAQ.CL
| $1.8M | 0.03% |
71,325
+6,100
| +9% | +$154K |
2013 Q2
3 quarters
|
|
207
Perrigo
PRGO
$2.29B
| $1.77M | 0.03% |
+11,465
| New | +$1.81M |
2014 Q1
0 quarters
|
|
208
Booking.com
BKNG
$125B
| $1.73M | 0.03% |
36,275
| – | – |
2013 Q3
2 quarters
|
|
|
PSXP
209
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $1.72M | 0.03% |
+35,390
| New | +$1.51M |
2014 Q1
0 quarters
|
|
210
O'Reilly Automotive
ORLY
$71.6B
| $1.72M | 0.03% |
173,550
-225
| -0.1% | -$2.15K |
2013 Q2
3 quarters
|
|
211
Unifirst Corp
UNF
$4.79B
| $1.71M | 0.03% |
15,583
-7,263
| -32% | -$789K |
2013 Q2
3 quarters
|
|
212
Jefferies Financial Group
JEF
$10.3B
| $1.71M | 0.03% |
68,124
+1,084
| +2% | +$26.7K |
2013 Q2
3 quarters
|
|
213
Fastenal
FAST
$57.8B
| $1.7M | 0.03% |
137,892
+29,176
| +27% | +$341K |
2013 Q2
3 quarters
|
|
214
Reinsurance Group of America
RGA
$17.2B
| $1.68M | 0.03% |
+21,065
| New | +$1.6M |
2014 Q1
0 quarters
|
|
|
NORD
215
DELISTED
Nord Anglia Education, Inc.
NORD
| $1.66M | 0.03% |
+86,668
| New | +$1.66M |
2014 Q1
0 quarters
|
|
216
WEC Energy
WEC
$34.6B
| $1.65M | 0.03% |
35,483
+4,405
| +14% | +$190K |
2013 Q2
3 quarters
|
|
217
CVS Health
CVS
$118B
| $1.64M | 0.03% |
21,914
+5,112
| +30% | +$361K |
2013 Q2
3 quarters
|
|
218
DELISTED
OILTANKING PARTNERS L P UIT LTD PARTNERSHIP INT (DE)
OILT
| $1.62M | 0.03% |
+41,980
| New | +$1.41M |
2014 Q1
0 quarters
|
|
219
IMAX
IMAX
$2.83B
| $1.6M | 0.03% |
58,453
-52,283
| -47% | -$1.43M |
2013 Q2
3 quarters
|
|
220
Cisco
CSCO
$433B
| $1.59M | 0.03% |
70,948
+33,042
| +87% | +$730K |
2013 Q2
3 quarters
|
|
|
AEK.CL
221
DELISTED
Aegon NV
AEK.CL
| $1.58M | 0.03% |
54,666
-200
| -0.4% | -$5.63K |
2013 Q2
3 quarters
|
|
222
Invesco Water Resources ETF
PHO
$1.95B
| $1.55M | 0.03% |
58,070
-8,540
| -13% | -$223K |
2013 Q2
3 quarters
|
|
223
Roper Technologies
ROP
$37.8B
| $1.54M | 0.03% |
+11,535
| New | +$1.57M |
2014 Q1
0 quarters
|
|
224
Norfolk Southern
NSC
$73B
| $1.54M | 0.03% |
15,819
+824
| +5% | +$76.4K |
2013 Q2
3 quarters
|
|
225
Bristol-Myers Squibb
BMY
$124B
| $1.53M | 0.03% |
29,540
+221
| +0.8% | +$11.8K |
2013 Q2
3 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2014 Portfolio in Review
As of Q1 2014, Geneva Advisors held 760 positions worth $5.44B, up 0.47% from $5.42B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geneva Advisors's Q1 2014 filing shows 155 new, 313 increased, 140 reduced and 45 closed positions. Its largest new stake was Methanex: 417,711 shares worth $26.7M. The largest sale was LKQ Corp, an estimated $54.6M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Geneva Advisors's largest Q1 2014 buy was Methanex: 417,711 shares worth $26.7M.
- Geneva Advisors added most to JPMorgan Chase in Q1 2014, an estimated $51.9M increase.
- Geneva Advisors's biggest Q1 2014 reduction was LKQ Corp, cutting an estimated $54.6M.
- Geneva Advisors fully exited QIWI PLC in Q1 2014, selling an estimated $26.1M.
- Geneva Advisors's ten largest holdings make up 19% of its $5.44B portfolio in Q1 2014.
- Geneva Advisors opened 155 new positions and closed 45 in Q1 2014.
- Geneva Advisors's portfolio value rose 0.47% quarter-over-quarter to $5.44B.
Based on Geneva Advisors's 13F filing for Q1 2014, filed 5 May 2014.